Discover

AKYA
Akoya Biosciences, Inc.
1.29
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
timesize
Ytd
1y
1.29
day range
1.29
0.93
52 week range
3.42
Open1.29Prev Close1.29Low1.29High1.29Mkt Cap64.44M
Vol715.25KAvg Vol582.12KEPS-0.96P/E-1.34Forward P/E-4.38
Beta1.36Short Ratio13.43Inst. Own70.19%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg1.22200-d Avg2.041yr Est3.50

AKYA News

AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
prnewswire.com
AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC

NEW ORLEANS , June 20, 2025 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal
prnewswire.com
Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alte

RINCON, Puerto Rico , May 23, 2025 /PRNewswire/ -- Kent Lake PR LLC ("Kent Lake"), a holder of appro

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates
zacks.com
Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.32 per share versus the Zacks Consensu

Akoya Biosciences Reports First Quarter 2025 Financial Results
globenewswire.com
Akoya Biosciences Reports First Quarter 2025 Financial Results

MARLBOROUGH, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA
businesswire.com
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
zacks.com
Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Akoya (AKYA) doesn't possess the right combination of the two key ingredients for a likely earnings

Quanterix and Akoya Biosciences Announce Amended Merger Agreement
businesswire.com
Quanterix and Akoya Biosciences Announce Amended Merger Agreement

BILLERICA, Mass. & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a comp

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
globenewswire.com
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial

MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The S

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
globenewswire.com
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-worl

MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The S

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore
globenewswire.com
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Design

The STCC Unified PD1/PDL1 Evaluation of Response (SUPER) study is a multi-institutional study led by

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences
businesswire.com
Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased f

CHARLOTTE, N.C.--(BUSINESS WIRE)--Tikvah Management LLC (together with its affiliates, “Tikvah” or “

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya
businesswire.com
Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”) is a holder of approximately 7.

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities
globenewswire.com
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational

Akoya's technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer E

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences
businesswire.com
Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Bioscie

CHARLOTTE, N.C.--(BUSINESS WIRE)--Tikvah Management LLC (together with its affiliates, “Tikvah” or “

Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates
zacks.com
Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates

Akoya Biosciences (AKYA) came out with a quarterly loss of $0.17 per share versus the Zacks Consensu

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
globenewswire.com
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoy

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call
businesswire.com
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction wit

RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”) is a holder of 7.47% of the out

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences
businesswire.com
Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Mer

RINCON, Puerto Rico--(BUSINESS WIRE)--Kent Lake PR LLC (“Kent Lake”), a holder of 5.9% of the outsta

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels
globenewswire.com
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiolo

Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently lau

Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner
businesswire.com
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner

CARLSBAD, Calif.--(BUSINESS WIRE)--Argonaut Manufacturing Services (“Argonaut”), a leading contract

benzinga.com
Earnings Scheduled For November 14, 2024

benzinga.com
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day

benzinga.com
Earnings Scheduled For March 4, 2024

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for it

benzinga.com
Earnings Scheduled For November 8, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 369 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For August 7, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 199 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 164 companies hit new 52-week lows.

benzinga.com
Earnings Scheduled For May 8, 2023

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday's trading, 110 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For March 6, 2023

Companies Reporting Before The Bell • Passage Bio (NASDAQ:PASG) is estimated to report earnings for

benzinga.com
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique

benzinga.com
Earnings Scheduled For November 7, 2022

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar

benzinga.com
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday

Gainers

benzinga.com
Earnings Scheduled For August 8, 2022

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo

benzinga.com
Earnings Scheduled For May 5, 2022

  Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.